GPT and metabolic dysfunction-associated steatohepatitis: Another study by Solhi et al. treated NASH patients with 210 mg of silymarin daily and after 8 weeks noted decreased alanine aminotransferase (ALT) and aspartate amino transferase (AST) levels in the treated group [13].